Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature., 579, 270, 10.1038/s41586-020-2012-7 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 382, 1708, 10.1056/NEJMoa2002032 Nikolich-Žugich, 2018, The twilight of immunity: emerging concepts in aging of the immune system, Nat. Immunol., 19, 10, 10.1038/s41590-017-0006-x Scully, 2020, Considering how biological sex impacts immune responses and COVID-19 outcomes, Nat. Rev. Immunol., 20, 442, 10.1038/s41577-020-0348-8 Koff, 2020, Covid-19 and immunity in aging populations — a new research agenda, N. Engl. J. Med., 10.1056/NEJMp2006761 Murin, 2019, Antibody responses to viral infections: a structural perspective across three different enveloped viruses, Nat. Microbiol., 4, 734, 10.1038/s41564-019-0392-y Woo, 2004, Longitudinal profile of immunoglobulin g (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus, Clin. Diagnostic Lab. Immunol., 11, 665 Ni, 2020, Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals, Immunity, 52, 971, 10.1016/j.immuni.2020.04.023 Zhao, 2020, Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Clin. Infect. Dis., 10.1093/cid/ciaa344 Bloch, 2020, Deployment of convalescent plasma for the prevention and treatment of COVID-19, J. Clin. Invest., 130, 2757, 10.1172/JCI138745 Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc. Natl. Acad. Sci., 117, 9490, 10.1073/pnas.2004168117 Chen, 2020, Convalescent plasma as a potential therapy for COVID-19, Lancet Infect. Dis., 20, 398, 10.1016/S1473-3099(20)30141-9 Bastard, 2020, Auto-antibodies against type I IFNs in patients with life-threatening COVID-19, Science (80-.), 10.1126/science.abd4585 Hartmann, 2017, Nucleic acid immunity, Adv. Immunol., 121, 10.1016/bs.ai.2016.11.001 Kikkert, 2020, Innate immune evasion by human respiratory RNA viruses, J. Innate Immun., 12, 4, 10.1159/000503030 Mesev, 2019, Decoding type I and III interferon signalling during viral infection, Nat. Microbiol., 4, 914, 10.1038/s41564-019-0421-x Schurz, 2019, The X chromosome and sex-specific effects in infectious disease susceptibility, Hum. Genomics, 13, 2, 10.1186/s40246-018-0185-z Klein, 2016, Sex differences in immune responses, Nat. Rev. Immunol., 16, 626, 10.1038/nri.2016.90 Newton, 2016, The host immune response in respiratory virus infection: balancing virus clearance and immunopathology, Semin. Immunopathol., 38, 471, 10.1007/s00281-016-0558-0 Klein, 2010, The Xs and Y of immune responses to viral vaccines, Lancet Infect, Dis., 10, 338 Klein, 2010, The impact of sex, gender and pregnancy on 2009 H1N1 disease, Biol. Sex Differ., 1, 5, 10.1186/2042-6410-1-5 Nussinovitch, 2012, The role of gender and organ specific autoimmunity, Autoimmun. Rev., 11, A377, 10.1016/j.autrev.2011.11.001 Carrel, 2005, X-inactivation profile reveals extensive variability in X-linked gene expression in females, Nature, 434, 400, 10.1038/nature03479 Tukiainen, 2017, Landscape of X chromosome inactivation across human tissues, Nature., 550, 244, 10.1038/nature24265 Kwon, 2019, Editorial: long non-coding RNAs and immunity, Front. Immunol., 10, 10.3389/fimmu.2019.02378 Souyris, 2018, TLR7 escapes X chromosome inactivation in immune cells, Sci. Immunol., 3, 10.1126/sciimmunol.aap8855 Nusbaum, 2020, Sex differences in systemic lupus erythematosus, mayo clin, Proc., 95, 384 Blanco, 2001, Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus, Science (80-.), 294, 1540, 10.1126/science.1064890 M.K, 2003, Microarray analysis of gene expression in lupus, Arthritis Res. Ther., 279 Fukuyama, 2000, Systemic lupus erythematosus after α-Interferon therapy for chronic hepatitis C: a case report and review of the literature, Am. J. Gastroenterol., 95, 310 Santiago-Raber, 2003, Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice, J. Exp. Med., 197, 777, 10.1084/jem.20021996 Christensen, 2006, Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus, Immunity., 25, 417, 10.1016/j.immuni.2006.07.013 Tan, 2018, Detection of microbial infections through innate immune sensing of nucleic acids, Annu. Rev. Microbiol., 72, 447, 10.1146/annurev-micro-102215-095605 Kassiotis, 2016, Immune responses to endogenous retroelements: taking the bad with the good, Nat. Rev. Immunol., 16, 207, 10.1038/nri.2016.27 Odhams, 2019, Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in systemic lupus erythematosus, Nat. Commun., 10, 10.1038/s41467-019-10106-2 Harris, 2019, Lysosomal pH is regulated in a sex dependent manner in immune cells expressing CXorf21, Front. Immunol., 10, 578, 10.3389/fimmu.2019.00578 Swiecki, 2015, The multifaceted biology of plasmacytoid dendritic cells, Nat. Rev. Immunol., 15, 471, 10.1038/nri3865 Jaillon, 2019, Sexual dimorphism in innate immunity, Clin. Rev. Allergy Immunol., 56, 308, 10.1007/s12016-017-8648-x Meier, 2009, Sex differences in the TLR-mediated response of pDCs to HIV-1 are associated with higher immune activation in infected women, Nat. Med., 15, 955, 10.1038/nm.2004 Berghöfer, 2006, TLR7 ligands induce higher IFN-α production in females, J. Immunol., 177, 2088, 10.4049/jimmunol.177.4.2088 Laffont, 2014, X-chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-Mediated IFN-α production of plasmacytoid dendritic cells from women, J. Immunol., 193, 5444, 10.4049/jimmunol.1303400 Seillet, 2012, The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling, Blood., 119, 454, 10.1182/blood-2011-08-371831 Griesbeck, 2015, Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN- production in women, J. Immunol., 195, 5327, 10.4049/jimmunol.1501684 Syrett, 2019, Diversity of epigenetic features of the inactive X-chromosome in NK cells, dendritic cells, and macrophages, Front. Immunol., 9, 3087, 10.3389/fimmu.2018.03087 Ciancanelli, 2015, Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency, Science (80-.), 348, 448, 10.1126/science.aaa1578 Blanco-Melo, 2020, Imbalanced host response to SARS-CoV-2 drives development of COVID-19, Cell., 181, 1036, 10.1016/j.cell.2020.04.026 Zhang, 2020, Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, Science (80-.), 10.1126/science.abd4570 Jefferies, 2019, Regulating IRFs in IFN driven disease, Front. Immunol., 10, 325, 10.3389/fimmu.2019.00325 Yu, 2018, Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity, Nat. Commun., 9, 10.1038/s41467-018-07384-7 Ong, 2020, A dynamic immune response shapes COVID-19 progression, Cell Host Microbe, 27, 879, 10.1016/j.chom.2020.03.021 Tailor, 2007, The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8, Immunity., 27, 228, 10.1016/j.immuni.2007.06.009 Banchereau, 2004, Autoimmunity through cytokine-induced dendritic cell activation, Immunity, 20, 539, 10.1016/S1074-7613(04)00108-6 Parmigiani, 2013, Impaired antibody response to influenza vaccine in HIV-Infected and uninfected aging women is associated with immune activation and inflammation, PLoS One, 8, 10.1371/journal.pone.0079816 Browne, 2009, Myd88 is required for an antibody response to retroviral infection, PLoS Pathog., 5, 10.1371/journal.ppat.1000298 Yu, 2012, Nucleic acid-sensing toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-Induced tumors, Immunity, 37, 867, 10.1016/j.immuni.2012.07.018 Clingan, 2013, B cell–Intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection, J. Immunol., 191, 810, 10.4049/jimmunol.1300244 Kasturi, 2011, Programming the magnitude and persistence of antibody responses with innate immunity, Nature, 470, 543, 10.1038/nature09737 Wang, 2016, Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X, Proc. Natl. Acad. Sci., 113, E2029, 10.1073/pnas.1520113113 Jego, 2003, Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6, Immunity., 19, 225, 10.1016/S1074-7613(03)00208-5 Bekeredjian-Ding, 2005, Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN, J. Immunol., 174, 4043, 10.4049/jimmunol.174.7.4043 Schuh, 2017, Human plasmacytoid dendritic cells display and shed B cell maturation antigen upon TLR engagement, J. Immunol., 198, 3081, 10.4049/jimmunol.1601746 Laurent, 2015, γ-secretase directly sheds the survival receptor BCMA from plasma cells, Nat. Commun., 6, 10.1038/ncomms8333 Vincent, 2019, Analysis of serum B cell‐activating factor from the tumor necrosis factor family (<scp>BAFF</scp>) and its soluble receptors in systemic lupus erythematosus, Clin. Transl. Immunol., 8, 10.1002/cti2.1047 Menon, 2016, A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus, Immunity, 44, 683, 10.1016/j.immuni.2016.02.012 Cervantes-Barragan, 2007, Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon, Blood, 109, 1131, 10.1182/blood-2006-05-023770 Deal, 2013, Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses, J. Clin. Invest., 123, 2464, 10.1172/JCI60945 Panem, 1982, ALPHA INTERFERON AND ANTIBODY TO ALPHA INTERFERON IN SYSTEMIC LUPUS ERYTHEMATOSUS11This work was supported by grants MV 129 from the American Cancer Society (to S.P.), AI-07057 and AI-12948 from the National Institute of Allergy and Infectious Diseases Wang, 2020, Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients, Cell Host Microbe, 10.1016/j.chom.2020.07.005 Netea, 2020, Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection, Cell, 181, 969, 10.1016/j.cell.2020.04.042 Arts, 2018, BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity, Cell Host Microbe, 23, 89, 10.1016/j.chom.2017.12.010 de Bree, 2018, The impact of sex hormones on BCG-induced trained immunity, J. Leukoc. Biol., 104, 573, 10.1002/JLB.5MA0118-027R Netea, 2020, Defining trained immunity and its role in health and disease, Nat. Rev. Immunol., 20, 375, 10.1038/s41577-020-0285-6 Sarai, 2013, WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition, EMBO J., 32, 2392, 10.1038/emboj.2013.176 Kamada, 2018, Interferon stimulation creates chromatin marks and establishes transcriptional memory, Proc. Natl. Acad. Sci., 115, E9162, 10.1073/pnas.1720930115 Barrat, 2019, Interferon target-gene expression and epigenomic signatures in health and disease, Nat. Immunol., 20, 1574, 10.1038/s41590-019-0466-2 Hole, 2019, Induction of memory-like dendritic cell responses in vivo, Nat. Commun., 10, 10.1038/s41467-019-10486-5 Prakash, 2013, Impaired secretion of interferons by dendritic cells from aged subjects to influenza, Age (Omaha), 35, 1785, 10.1007/s11357-012-9477-8 Ma, 2017, Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs, J. Exp. Med., 214, 1471, 10.1084/jem.20161149 Gubbels Bupp, 2015, Sex, the aging immune system, and chronic disease, Cell. Immunol., 294, 102, 10.1016/j.cellimm.2015.02.002 Jing, 2009, Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood, Hum. Immunol., 70, 777, 10.1016/j.humimm.2009.07.005 Blomberg, 2013, Age effects on mouse and human B cells, Immunol. Res., 57, 354, 10.1007/s12026-013-8440-9 Frasca, 2017, Human peripheral late/exhausted memory B cells express a senescent-associated secretory phenotype and preferentially utilize metabolic signaling pathways, Exp. Gerontol., 87, 113, 10.1016/j.exger.2016.12.001 Nevalainen, 2019, CD27- IgD- B cell memory subset associates with inflammation and frailty in elderly individuals but only in males, Immun. Ageing, 16, 19, 10.1186/s12979-019-0159-6 van der Geest, 2016, Aging-dependent decline of IL-10 producing B cells coincides with production of antinuclear antibodies but not rheumatoid factors, Exp. Gerontol., 10.1016/j.exger.2015.12.009 Berggren, 2017, Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype, PLoS One, 10.1371/journal.pone.0183946 Castelo-Branco, 2014, The immune system and aging: a review, Gynecol. Endocrinol., 30, 16, 10.3109/09513590.2013.852531 Li, 2020, Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Nat. Rev. Drug Discov., 10.1038/d41573-020-00016-0 Hung, 2020, Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet, 10.1016/S0140-6736(20)31042-4 Xie, 2020, Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19, Antivir. Ther. (Lond.), 10.3851/IMP3362 Zuo, 2020, Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: a retrospective study in two designated hospitals in Anhui, China, J. Med. Virol., 92, 2666, 10.1002/jmv.26127